Dapagliflozin
98 %
- Product Code: 53681
Alias:
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; Dapagliflozin; Dag Liejing; Telaprevir; (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol ;
CAS:
461432-26-8
| Molecular Weight: | 408.88 g./mol | Molecular Formula: | C₂₁H₂₅ClO₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.349g/cm3 | Storage Condition: | room temperature |
Product Description:
Dapagliflozin is primarily used in the management of type 2 diabetes mellitus. It works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which helps to lower blood glucose levels by promoting the excretion of excess glucose through urine. This mechanism of action is beneficial for patients who need better glycemic control, especially when other medications are not sufficient. Additionally, dapagliflozin has shown benefits in reducing the risk of cardiovascular events, such as heart failure, in patients with type 2 diabetes. It is also used in the treatment of heart failure with reduced ejection fraction, even in patients without diabetes, as it helps to improve heart function and reduce hospitalizations. Furthermore, dapagliflozin has been found to aid in weight loss and lower blood pressure, providing additional health benefits for patients with metabolic and cardiovascular conditions.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 97.5 100% |
| Appearance | Light yellow to White amorphous solid |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 | 10-20 days | $44.40 |
+
-
|
| 1.000 | 10-20 days | $145.81 |
+
-
|
| 5.000 | 10-20 days | $419.44 |
+
-
|
| 25.000 | 10-20 days | $1,367.84 |
+
-
|
Dapagliflozin
Dapagliflozin is primarily used in the management of type 2 diabetes mellitus. It works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which helps to lower blood glucose levels by promoting the excretion of excess glucose through urine. This mechanism of action is beneficial for patients who need better glycemic control, especially when other medications are not sufficient. Additionally, dapagliflozin has shown benefits in reducing the risk of cardiovascular events, such as heart failure, in patients with type 2 diabetes. It is also used in the treatment of heart failure with reduced ejection fraction, even in patients without diabetes, as it helps to improve heart function and reduce hospitalizations. Furthermore, dapagliflozin has been found to aid in weight loss and lower blood pressure, providing additional health benefits for patients with metabolic and cardiovascular conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :